![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/fda-asks-covid-vaccine-makers-target-kp2-strain-with-updated-shots-2024-06-14/
https://www.prnewswire.com/news-releases/novavax-submits-application-to-us-fda-for-updated-protein-based-2024-2025-formula-covid-19-vaccine-302173290.html
https://www.pharmaceutical-technology.com/news/fda-recommends-updated-covid-19-vaccines-targeting-jn-1/
https://www.prnewswire.com/news-releases/novavax-to-participate-in-2024-jefferies-global-healthcare-conference-302158433.html
https://www.reuters.com/business/healthcare-pharmaceuticals/shah-capital-ends-campaign-against-novavax-board-after-sanofi-deal-2024-05-20/
https://www.fiercepharma.com/pharma/serum-institute-deploys-first-doses-oxford-novavax-partnered-malaria-shot-africa
https://www.reuters.com/business/healthcare-pharmaceuticals/frances-sanofi-covid-19-vaccine-deal-with-novavax-statement-2024-05-10/
https://www.prnewswire.com/news-releases/novavax-reports-first-quarter-2024-financial-results-and-operational-highlights-302142108.html
https://www.prnewswire.com/news-releases/novavax-and-sanofi-announce-co-exclusive-licensing-agreement-to-co-commercialize-covid-19-vaccine-and-develop-novel-covid-19-influenza-combination-vaccines-302142096.html